Short answer: a marketing agency typically delivers a defined service — paid media, SEO, creative production, or similar. A fractional CMO typically owns the decisions that sit above those services: priorities, budget trade-offs, who does what, and what the results mean for the business. The two aren't mutually exclusive. Many telehealth businesses run a fractional CMO and one or more agencies at the same time, with the CMO coordinating the plan the agencies execute against. Fractional leadership tends to work best when the engagement defines the actual work rather than just the title, with clear check-in points — divided attention across clients is a genuine risk worth planning for, not a reason to skip the definition step.3
This isn't a case for one being superior to the other. Agencies can be strategic, accountable, and well-run on their own. The real question is whether your business currently has someone who owns the cross-functional decisions — and if not, who should.
A fair comparison
| Marketing agency | Fractional CMO | |
|---|---|---|
| Typical engagement | A defined service: paid media, SEO, creative, production | Ongoing part-time leadership, often combined with scoped execution |
| Primary accountability | Delivering the contracted service well | Connecting the service results to the commercial objective |
| Who sets priorities | Usually the client, with agency input on their channel | The CMO, in agreement with the founder |
| Who approves budget | The client approves; the agency recommends within its channel | The CMO recommends across channels; the founder approves |
| Clinical/legal ownership | Neither role owns this — your qualified advisers do | Same — neither role replaces clinical or legal review |
| Works across channels | Sometimes, if the agency is full-service | Yes, by design — that's the coordinating function |
| Replaces the other role | No | No — can run alongside an agency rather than replacing it |
Treat this as a starting framework, not a universal rule. Agency scopes vary widely, and some agencies already operate with a strategic, accountable relationship to the client's business outcomes.
Clinical and operational ownership: a distinction worth naming
For telehealth and telemedicine brands specifically, neither an agency nor a fractional CMO should be mistaken for a clinical or legal function. An initial marketing assessment works from aggregate performance data — ad account structure, funnel conversion, reporting views — not patient records. A marketing role can coordinate the claims-review and platform health-policy process — flagging language, routing drafts, keeping a checklist — but final approval on claims, clinical content, and anything involving protected health information belongs to your clinical and legal advisers, not to either marketing role. The U.S. Department of Health and Human Services has published guidance on how online tracking technology intersects with HIPAA obligations when protected health information is involved; it's a reasonable starting reference for your privacy counsel, not a substitute for their review.1
Who approves spend?
This is usually the clearest dividing line in practice:
- An agency typically recommends spend changes within its own channel and executes once the client approves.
- A fractional CMO typically recommends spend allocation across channels and workstreams, bringing the agency's recommendation into a broader view of what the business can fund and what else is competing for that budget.
- The founder or a designated finance owner approves the budget in both cases. Neither role should have unchecked authority over spend — that's a structural risk, not a feature.
Gartner's research on CMO budget behavior frames this as portfolio management: treating the marketing budget as a set of deliberate trade-offs between acquisition and retention investment, rather than a fixed allocation renewed by habit.2 McKinsey's research on CMO integration makes a related point from the finance side — agreeing acquisition and lifetime-value metrics with the CFO, rather than letting spend decisions sit with whoever owns the loudest channel.4 That framing applies whether the person managing the portfolio is a full-time CMO, a fractional one, or a founder doing it personally — the discipline matters more than the title.
The agency-plus-CMO option
A common and often underrated setup: keep the agency (or agencies) doing the channel work they're good at — telehealth-specific paid media and funnel work is one example of that kind of channel delivery — and bring in a fractional CMO to:
- Set the shared priorities and a review cadence across agencies that otherwise report in isolation
- Decide what gets tested, paused, or funded next when two specialists disagree
- Translate platform-level reporting into a business decision about budget
- Own the connective tissue — CRM handoffs, attribution definitions, follow-up — that no single agency is positioned to own
This isn't a knock on the agencies. It's a recognition that coordinating multiple specialists is itself a job, and it tends to go better when someone is explicitly responsible for it.
A role matrix for mixed engagements
The split below is illustrative, not a universal standard — it reflects one reasonable way to divide the work, and your actual contract should spell out who holds each decision rather than assuming this default. In particular, how much creative the founder reviews personally versus delegates is a scope choice, not a fixed rule.
| Decision | Agency | Fractional CMO | Founder |
|---|---|---|---|
| Channel-level creative and targeting | Owns | Reviews for fit with broader plan | Final approval on direction |
| Cross-channel budget allocation | Provides input | Recommends | Approves |
| Which test runs next | Proposes within channel | Prioritizes across channels | Approves if above agreed threshold |
| Clinical/legal claims review | Flags issues it identifies | Coordinates the review and routing | Confirms adviser sign-off before launch |
| Reporting definitions and reconciliation | Reports its own numbers | Owns the shared definition | Reviews |
A total-cost framework, not a number
There's no comparable verified benchmark for "agency cost vs. fractional CMO cost" used here — spend ranges by agency scope, channel mix, and region too widely for a single published number to mean much applied to your business. Instead of looking for an average, compare your actual proposals using categories that separate the cost drivers:
- Leadership and coordination time — is anyone currently paid, explicitly, to own the cross-channel decisions? If not, that's a gap with a cost even when it isn't itemized.
- Execution capacity — creative production, campaign management, page builds. Priced per workstream, whether delivered by an agency, a fractional CMO's scoped execution, or internal staff.
- Media spend — kept separate from any leadership or execution fee, regardless of who's directing it.
- Software and tooling — attribution, CRM, ad platforms — often shared infrastructure regardless of who's managing the account.
- Opportunity cost of no owner — harder to quantify, but real: decisions that stall, specialists working against different priorities, budget that sits in the wrong channel for a quarter because nobody reconciled the reports.
Price out your actual proposals against these categories before comparing a headline monthly number. See the fractional CMO cost and scope breakdown for a worksheet built around this structure.
Questions to ask before hiring either
- Who, specifically, is deciding where the next dollar of budget goes — and do they see the full picture or just one channel?
- If two specialists disagree about priorities, who resolves it?
- What decisions are explicitly out of scope — clinical, legal, or otherwise — and who owns those instead?
- How will we know if this is working, separate from platform-reported metrics? See why cheaper leads can cost more for how acquisition cost should actually be calculated.
- What happens to institutional knowledge if this engagement ends — is anything documented outside one person's head?
Where this fits for telehealth brands specifically
My own work sits in the fractional CMO column, with scoped execution built in rather than handed off: I can run alongside your existing agency relationships, coordinating priorities rather than replacing the work they already do well. The fractional CMO scope and approach covers the scope, pricing, and fit in detail. If you're not sure whether your business needs this kind of role at all yet, start with when to hire a fractional CMO.
Ready to talk through your specific mix of agencies, internal team, and gaps? Book a strategy call.
Sources
1. HHS Office for Civil Rights, HIPAA and Online Tracking Technologies guidance
2. Gartner, CMO Spend survey coverage
3. Harvard Business Review, How to Make Fractional Leadership Work
4. McKinsey & Company, The CMO's Comeback: Aligning the C-Suite to Drive Customer-Centric Growth